News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
319,875 Results
Type
Article (15413)
Company Profile (291)
Press Release (304171)
Multimedia
Podcasts (50)
Webinars (7)
Section
Business (92876)
Career Advice (318)
Deals (18625)
Drug Delivery (37)
Drug Development (53635)
Employer Resources (41)
FDA (6782)
Job Trends (6499)
News (169239)
Policy (13159)
Tag
Academia (997)
Accelerated approval (2)
Adcomms (12)
Allergies (54)
Alliances (25465)
ALS (75)
Alzheimer's disease (936)
Antibody-drug conjugate (ADC) (106)
Approvals (6812)
Artificial intelligence (133)
Autoimmune disease (21)
Automation (7)
Bankruptcy (180)
Best Places to Work (5803)
BIOSECURE Act (7)
Biosimilars (57)
Biotechnology (238)
Bladder cancer (65)
Brain cancer (20)
Breast cancer (178)
Cancer (1613)
Cardiovascular disease (127)
Career advice (276)
Career pathing (2)
CAR-T (127)
Cell therapy (351)
Cervical cancer (12)
Clinical research (43841)
Collaboration (580)
Compensation (287)
Complete response letters (15)
COVID-19 (1135)
CRISPR (44)
C-suite (179)
Cystic fibrosis (82)
Data (1701)
Denatured (11)
Depression (35)
Diabetes (157)
Diagnostics (1954)
Digital health (5)
Diversity (2)
Diversity, equity & inclusion (14)
Drug discovery (89)
Drug pricing (30)
Drug shortages (9)
Duchenne muscular dystrophy (92)
Earnings (34834)
Editorial (20)
Employer branding (5)
Employer resources (40)
Events (55041)
Executive appointments (516)
FDA (7631)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (550)
Gene editing (105)
Generative AI (10)
Gene therapy (261)
GLP-1 (403)
Government (1333)
Grass and pollen (2)
Guidances (68)
Healthcare (7972)
Huntington's disease (23)
IgA nephropathy (25)
Immunology and inflammation (97)
Indications (21)
Infectious disease (1210)
Inflammatory bowel disease (123)
Inflation Reduction Act (8)
Influenza (24)
Intellectual property (71)
Interviews (52)
IPO (10183)
IRA (13)
Job creations (1028)
Job search strategy (242)
Kidney cancer (7)
Labor market (8)
Layoffs (228)
Leadership (4)
Legal (2790)
Liver cancer (39)
Lung cancer (219)
Lymphoma (109)
Machine learning (4)
Management (10)
Manufacturing (162)
MASH (58)
Medical device (4226)
Medtech (4227)
Mergers & acquisitions (8896)
Metabolic disorders (435)
Multiple sclerosis (59)
NASH (15)
Neurodegenerative disease (73)
Neuropsychiatric disorders (25)
Neuroscience (1379)
NextGen: Class of 2025 (2762)
Non-profit (1020)
Now hiring (22)
Obesity (221)
Opinion (110)
Ovarian cancer (68)
Pain (53)
Pancreatic cancer (64)
Parkinson's disease (127)
Partnered (11)
Patents (155)
Patient recruitment (86)
Peanut (37)
People (29299)
Pharmaceutical (47)
Pharmacy benefit managers (6)
Phase I (15228)
Phase II (20287)
Phase III (13157)
Pipeline (975)
Policy (54)
Postmarket research (968)
Preclinical (6356)
Press Release (31)
Prostate cancer (69)
Psychedelics (36)
Radiopharmaceuticals (221)
Rare diseases (311)
Real estate (1873)
Recruiting (16)
Regulatory (10292)
Reports (19)
Research institute (1040)
Resumes & cover letters (36)
Rett syndrome (4)
RNA editing (5)
RSV (13)
Schizophrenia (63)
Series A (103)
Series B (69)
Service/supplier (1)
Sickle cell disease (44)
Special edition (12)
Spinal muscular atrophy (119)
Sponsored (12)
Startups (2225)
State (2)
Stomach cancer (5)
Supply chain (29)
Tariffs (11)
The Weekly (38)
Vaccines (252)
Venture capitalists (32)
Weight loss (125)
Women's health (15)
Worklife (2)
Date
Today (152)
Last 7 days (586)
Last 30 days (1890)
Last 365 days (21494)
2025 (7513)
2024 (22892)
2023 (25307)
2022 (30672)
2021 (32237)
2020 (27928)
2019 (20272)
2018 (14858)
2017 (16345)
2016 (14176)
2015 (17431)
2014 (12648)
2013 (9419)
2012 (9642)
2011 (9531)
2010 (9133)
Location
Africa (165)
Alabama (43)
Alaska (2)
Arizona (80)
Arkansas (5)
Asia (19757)
Australia (3222)
California (4365)
Canada (1229)
China (392)
Colorado (162)
Connecticut (170)
Delaware (128)
Europe (41471)
Florida (561)
Georgia (142)
Idaho (24)
Illinois (271)
India (12)
Indiana (137)
Iowa (2)
Japan (92)
Kansas (66)
Kentucky (7)
Louisiana (3)
Maine (46)
Maryland (550)
Massachusetts (3376)
Michigan (134)
Minnesota (180)
Mississippi (2)
Missouri (34)
Montana (15)
Nebraska (7)
Nevada (42)
New Hampshire (21)
New Jersey (1155)
New Mexico (13)
New York (1181)
North Carolina (695)
North Dakota (5)
Northern California (1933)
Ohio (129)
Oklahoma (9)
Oregon (23)
Pennsylvania (868)
Puerto Rico (6)
Rhode Island (20)
South America (265)
South Carolina (9)
Southern California (1666)
Tennessee (38)
Texas (576)
United States (15401)
Utah (80)
Virginia (88)
Washington D.C. (31)
Washington State (382)
West Virginia (1)
Wisconsin (19)
319,875 Results for "resolve therapeutics llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ITF Therapeutics LLC Announces Opening of New U.S. Headquarters in Concord, Massachusetts
March 5, 2025
·
6 min read
Drug Development
Resolve Therapeutics Publishes Results of RSLV-132 Phase 2 Long COVID Study
Resolve Therapeutics today announced the publication of its phase 2 long COVID results in Clinical Infectious Diseases.
May 13, 2024
·
2 min read
Press Releases
Paradigm Therapeutics, Inc. Announces Investment by Eshelman Ventures, LLC to Support Completion of Development of SD-101 (Zorblisa™), A Topical Therapy for Treatment Across the Entire Skin Surface of All Subtypes of Epidermolysis Bullosa (EB)
May 7, 2025
·
5 min read
Press Releases
ITF Therapeutics LLC Announces Multiple Data Presentations at 2025 MDA Clinical and Scientific Conference
February 21, 2025
·
7 min read
Press Releases
Axsome Therapeutics Announces Settlement Agreement Resolving AUVELITY® (dextromethorphan HBr – bupropion HCl) Patent Litigation
February 10, 2025
·
5 min read
Press Releases
Innovative Lab Services LLC Acquires Compco Analytical, Inc.
May 1, 2025
·
1 min read
Press Releases
ITF Therapeutics LLC Presents Long-Term Data of DUVYZAT™ (givinostat) for Treatment of Duchenne Muscular Dystrophy at MDA Clinical and Scientific Conference
March 18, 2025
·
7 min read
BioMidwest
Inotiv Reaches Agreement to Resolve Previously-Announced Investigation into Shuttered Cumberland Facility
Inotiv Inc. announced that it reached an agreement with the U.S. Department of Justice to resolve a previously-announced criminal investigation into the shuttered canine breeding facility located in Cumberland, Virginia, which was operated originally by Envigo RMS LLC, a company acquired by Inotiv in November 2021.
June 3, 2024
·
5 min read
Press Releases
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
April 22, 2025
·
2 min read
Pharm Country
Johnson & Johnson Announces Plan by its Subsidiary, LLT Management LLC, to Resolve All Current and Future Ovarian Cancer Talc Claims Through a Consensual “Prepackaged” Reorganization
Johnson & Johnson announced a proposed Plan of Reorganization by its subsidiary, LLT Management LLC, for the comprehensive and final resolution of all current and future claims related to ovarian cancer arising from cosmetic talc litigation against it and its affiliates in the United States.
May 1, 2024
·
8 min read
1 of 31,988
Next
